Congrès France
Bioproduction
5ème édition
17 & 18 juin 2021

Rassembler et fédérer tous les acteurs au service de la filière

Just-Evotec Biologics

Partenaire Gold

Unique Biologics discovery to manufacturing platform aiming at derisking & accelerating CMC through to commercial launch.

Just – Evotec Biologics offers cutting-edge technologies spanning from antibody discovery through to clinical and commercial Drug Substance manufacturing. Combination of artificial intelligence, machine learning, continuous biomanufacturing processes with highly-flexible facility design is providing a powerful and unique end-to-end integrated biologics platform to our Biotech and Pharma partners. Our team can support programs all the way from early discovery stages with the identification of  truly “developable” lead candidates up to the development of robust, more productive and cost-effective biomanufacturing processes which we perform in our differentiated J.POD® facilities to meet both clinical or commercial demands by applying scale-out strategies.

We can support standard or more complex antibody/multibody and protein fusion formats as part of classic First-in Human program or more comprehensive and integrated discovery to CMC partnerships where we can actually provide in-depth therapeutic area expertise beyond the access to technology platforms. 

Discovery and Molecular Design Platforms

Ces innovations pédagogiques sont déployées dans le cadre des formations initiales et continues. Le Groupe IMT propose un catalogue de formations e-learning, des enseignements à distance, des contenus vidéos et tutoriels qui peuvent s’intégrer dans un jumeau numérique. Ce dernier utilise la réalité virtuelle au service de la formation initiale et continue. La réalité virtuelle et le jumeau numérique permettent d’entrer dans des zones contrôlées : une approche complémentaire aux plateaux techniques et aux mini-usines développés par le Groupe IMT. L’objectif est d’appréhender une multitude d’équipements et de bénéficier d’un droit à l’erreur pour l’apprenant et le salarié.

First-in-Human (FIH) Program

Our process development platform leverages high throughput technology to rapidly deliver robust manufacturing processes.

  • Proprietary / client supplied cell lines, vectors, and media with process options for continuous, intensified manufacturing relying on perfusion mode.
  • Chromatography, filtration, and viral clearance capabilities for removal of impurities
  • Biophysical and formulation development tools for defining optimal storage stability
  • High resolution analytical capabilities, including mass spectrometry based multi-attribute method (MAM)

Clinical and commercial manufacturing services performed at our J.POD flexible and deployable facilities designed to improve speed and cost-effectiveness of manufacturing, while never compromising quality.

 

Shopping Basket